Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
87:S9-S15
Semaglutide can slow bowel movement, leading to feeling full, but inappropriate dosing can cause bowel obstruction, requiring surgery
Many anabolic and hormone-modulating compounds appear on the Department of Defenses prohibited ingredients list and may trigger adverse findings in readiness or medical screenings
Current law blocks Medicare weight-loss drug coverage Policy changes expected mid-2026 Medicaid coverage remains state-dependent What This Means for You Coverage is stable: Wegovy's preferred status on Aetna expected to continue Focus on PA requirements: Meeting criteria is key to approval Cardiovascular benefit: Wegovy's heart health approval (March 2024) strengthens your case During open enrollment: Confirm no changes to your specific plan's requirements CALL YOUR INSURANCE Verify Your Specific Coverage Verify Your Specific Coverage Even though it takes a little more time, we recommend calling so you can speak with a person who may have more information than the online directory or PDF formulary listing
